RecruitingNCT03408353

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort

Sponsor

M.D. Anderson Cancer Center

Enrollment

10,000 participants

Start Date

Sep 15, 2017

Study Type

OBSERVATIONAL

Conditions

Breast Carcinoma

Summary

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.

Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is looking for early biological signs (biomarkers) in blood and breast tissue that could help predict who is at risk of developing breast cancer, alongside newer imaging technologies used during routine mammogram screening. **You may be eligible if...** - You are coming in for a routine screening mammogram at a participating location - You are willing to complete a health questionnaire and provide a blood sample at your initial visit and during annual follow-up visits - You have not been recently breastfeeding (within the last 6 months) **You may NOT be eligible if...** - You have a personal history of breast cancer (including DCIS) - You have been breastfeeding within the past 6 months - You are unwilling to provide blood samples or complete the questionnaire Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.